Publicacións (207) Publicacións de María José Alonso Fernández Ver datos de investigación referenciados.

2024

  1. A journey through the history of PEGylated drug delivery nanocarriers

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2026-2031

  2. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology

  3. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  4. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  5. Controlling the protein corona of polymeric nanocapsules: effect of polymer shell on protein adsorption

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 918-933

  6. Editorial note

    Drug Delivery and Translational Research

  7. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights

    Nano Research, Vol. 17, Núm. 10, pp. 9111-9125

  8. Fifty years of sciences with Patrick Couvreur: A tribute to Professor Patrick Couvreur: a creative and visionary scientist in the field of nanomedicine

    Drug Delivery and Translational Research

  9. Formulation of protein-loaded nanoparticles via freeze-drying

    Drug Delivery and Translational Research

  10. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

  11. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

  12. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  13. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2046-2061

  14. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors

    Journal of Controlled Release, Vol. 373, pp. 277-292

  15. Performance of a Modular Ton-Scale Pixel-Readout Liquid Argon Time Projection Chamber

    Instruments, Vol. 8, Núm. 3

  16. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals

    Advanced Materials, Vol. 36, Núm. 14

2023

  1. Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

    Pharmaceutics, Vol. 15, Núm. 6

  2. Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis

    Journal of Controlled Release, Vol. 360, pp. 747-758

  3. Editorial note

    Drug Delivery and Translational Research

  4. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages

    Drug Delivery and Translational Research, Vol. 13, Núm. 7, pp. 1896-1911